GleamWall
中文EN

GANX Gain Therapeutics, Inc.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1819411 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY7.3%
TTM EPS YoY31.1%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-223.9%
ROA-148.6%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets23.3%
Debt / equity0.03x
Current ratio5.36x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.95x
Accruals ratio-7.5%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue——
R&D expense$10.21M$10.79M
SG&A expense$8.50M$9.56M
Operating income-$18.71M-$20.35M
Pretax income-$19.30M-$19.87M
Income tax$861,118$536,815
Net income-$20.16M-$20.41M
EBITDA-$18.62M-$20.27M
EPS (basic)-0.61-0.89
EPS (diluted)-0.61-0.89
Weighted avg. shares (diluted)32.97M22.88M
Balance sheet
Cash & equivalents$20.84M$10.42M
Current assets$22.24M$11.60M
PP&E, net$74,916$103,619
Intangibles$102,837—
Total assets$22.82M$12.12M
Current liabilities$3.35M$3.91M
Short-term debt$100,869$110,177
Long-term debt$300,084$328,327
Total debt$400,953$438,504
Total liabilities$4.25M$4.78M
Shareholders' equity$18.56M$7.34M
Net debt-$20.44M-$9.98M
Shares outstanding42.07M27.13M
Cash flow statement
Operating cash flow-$18.47M-$18.87M
Capital expenditure—$22,493
Free cash flow—-$18.90M
Investing cash flow—$4.98M
Financing cash flow$28.45M$13.01M
Depreciation & amortization$94,046$84,071
Stock-based compensation$1.80M$2.39M

Free plan shows the latest 2 periods; Pro shows all 6 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.